search
Back to results

The Natriuretic Peptide System in African-Americans.

Primary Purpose

Healthy, Prehypertension

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Low-Salt Diet
High-Salt Diet
Sponsored by
Vanderbilt University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Healthy

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • age between 18 and 55 years
  • BMI between 18 and <25 kg/m2
  • normotensive or pre-hypertensive
  • willing to adhere to study diets

Exclusion Criteria:

  • prevalent cardiovascular disease or use of medications for cardiovascular disease
  • Current or prior history of hypertension or use of blood pressure lowering medications
  • Current or prior history of diabetes mellitus or use of anti-diabetic medications
  • Prevalent renal disease (eGFR < 60 ml/min/1.73m2), abnormal serum sodium or potassium
  • Current or prior smoker
  • Current pregnancy
  • Current steroid use
  • Contraindications to MRI

Sites / Locations

  • Vanderbilt Univeristy

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

African-American

Whites

Arm Description

40 healthy African-American subjects will be enrolled and each will undergo study procedures at 4 separate visits, with each visit occurring 7-days apart. After a baseline visit, the subject will begin either a low-salt or high-salt diet, based upon randomization assignment to one of the two following dietary protocols: A) low-salt diet, washout, then high-salt diet; or B) high-salt diet, washout, then low-salt diet. Each dietary or washout period lasts for 7 days.

40 healthy white subjects will be enrolled and each will undergo study procedures at 4 separate visits, with each visit occurring 7-days apart. After a baseline visit, the subject will begin either a low-salt or high-salt diet, based upon randomization assignment to one of the two following dietary protocols: A) low-salt diet, washout, then high-salt diet; or B) high-salt diet, washout, then low-salt diet. Each dietary or washout period lasts for 7 days.

Outcomes

Primary Outcome Measures

The difference in circulating NT-proANP levels in response to low and high dietary salt.

Secondary Outcome Measures

Tissue sodium content
Measured by sodium MRI
Blood pressure
Salt-sensitive hypertension
Measured by change in mean arterial pressure
Urinary sodium excretion
Measured from 24 hour urine collection
Myocardial early relaxation velocities
Measured from Echocardiography as tissue Doppler e'
Plasma renin
Physiological parameter
Serum aldosterone
Physiological parameter

Full Information

First Posted
March 29, 2016
Last Updated
November 8, 2022
Sponsor
Vanderbilt University
search

1. Study Identification

Unique Protocol Identification Number
NCT02730780
Brief Title
The Natriuretic Peptide System in African-Americans.
Official Title
The Natriuretic Peptide System in African-Americans.
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
July 22, 2016 (Actual)
Primary Completion Date
May 20, 2021 (Actual)
Study Completion Date
May 20, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to assess the natriuretic peptide response to dietary salt loading in African-American individuals compared with white individuals.
Detailed Description
High blood pressure, or hypertension, is a major cause of heart disease, heart failure, and stroke. Natriuretic peptides are cardiac derived hormones that may protect against hypertension. The classical actions of the natriuretic peptides include natriuresis, vasodilation, and inhibition of the renin-angiotensin-aldosterone system (RAAS), which support a key role for these hormones in blood pressure regulation. Race based differences exist in the risk and severity of hypertension and cardiovascular disease, with African-American individuals typically being at greater risk compared with white individuals. Nearly half of African-American adults have hypertension, compared with one-third of whites. Additionally, salt-sensitivity denotes the impaired ability to handle a salt load with resulting increases in blood pressure. It is estimated that 75% of hypertensive African-Americans exhibit salt-sensitivity, compared with 35% of hypertensive whites. Why this predilection towards salt-sensitivity exists, particularly among African-American individuals, is not well understood. Thus, establishing the origins of salt retention in African Americans has biologic, preventative, and therapeutic importance, and may provide insight regarding racial differences in cardiovascular risk. The natriuretic peptide system is the principal counter-regulatory mechanism to salt retention. However, little is known regarding racial differences in the natriuretic peptide system. Recently, it was discovered that African-Americans have lower natriuretic peptide levels compared with whites, raising the possibility that African-Americans individuals can have a relative "natriuretic peptide deficiency" with reduced natriuretic peptide responses to salt loading. However, the prior studies were based on epidemiologic data with individuals on random salt backgrounds. This highlights the need for more detailed physiologic studies, under controlled salt conditions and with standardized assessment of the natriuretic peptide and RAAS and tissue sodium stores. The aim of this study is to assess the natriuretic peptide response to dietary salt loading in African-American individuals compared with white individuals. This study will test the primary hypothesis that compared with whites, African-American individuals have blunted natriuretic peptide responses to dietary salt loading. Secondary hypotheses include: Compared with white individuals, African-American individuals have higher baseline tissue sodium content, and Compared with white individuals, African-American individuals have impaired "target organ" responses to salt loading, as manifested by higher blood pressure and increased frequency of salt-sensitive hypertension, decreased urinary sodium excretion, less suppression of plasma renin and serum aldosterone, and lack of increase in left ventricular early diastolic relaxation velocities.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy, Prehypertension

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
African-American
Arm Type
Other
Arm Description
40 healthy African-American subjects will be enrolled and each will undergo study procedures at 4 separate visits, with each visit occurring 7-days apart. After a baseline visit, the subject will begin either a low-salt or high-salt diet, based upon randomization assignment to one of the two following dietary protocols: A) low-salt diet, washout, then high-salt diet; or B) high-salt diet, washout, then low-salt diet. Each dietary or washout period lasts for 7 days.
Arm Title
Whites
Arm Type
Other
Arm Description
40 healthy white subjects will be enrolled and each will undergo study procedures at 4 separate visits, with each visit occurring 7-days apart. After a baseline visit, the subject will begin either a low-salt or high-salt diet, based upon randomization assignment to one of the two following dietary protocols: A) low-salt diet, washout, then high-salt diet; or B) high-salt diet, washout, then low-salt diet. Each dietary or washout period lasts for 7 days.
Intervention Type
Dietary Supplement
Intervention Name(s)
Low-Salt Diet
Intervention Description
The low-salt diet (7 days) will consist of meals, snacks, and sodium free water provided by the study staff.
Intervention Type
Dietary Supplement
Intervention Name(s)
High-Salt Diet
Intervention Description
The high-salt diet (7 days) consists of each subject's usual diet, supplemented each day with 2 bouillon broth packets, which will be provided to the subject by the study staff.
Primary Outcome Measure Information:
Title
The difference in circulating NT-proANP levels in response to low and high dietary salt.
Time Frame
4 years
Secondary Outcome Measure Information:
Title
Tissue sodium content
Description
Measured by sodium MRI
Time Frame
4 years
Title
Blood pressure
Time Frame
4 years
Title
Salt-sensitive hypertension
Description
Measured by change in mean arterial pressure
Time Frame
4 years
Title
Urinary sodium excretion
Description
Measured from 24 hour urine collection
Time Frame
4 years
Title
Myocardial early relaxation velocities
Description
Measured from Echocardiography as tissue Doppler e'
Time Frame
4 years
Title
Plasma renin
Description
Physiological parameter
Time Frame
4 years
Title
Serum aldosterone
Description
Physiological parameter
Time Frame
4 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age between 18 and 55 years BMI between 18 and <25 kg/m2 normotensive or pre-hypertensive willing to adhere to study diets Exclusion Criteria: prevalent cardiovascular disease or use of medications for cardiovascular disease Current or prior history of hypertension or use of blood pressure lowering medications Current or prior history of diabetes mellitus or use of anti-diabetic medications Prevalent renal disease (eGFR < 60 ml/min/1.73m2), abnormal serum sodium or potassium Current or prior smoker Current pregnancy Current steroid use Contraindications to MRI
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Deepak K Gupta, MD
Organizational Affiliation
Vanderbilt Cardiovascular Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vanderbilt Univeristy
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
26071618
Citation
Gupta DK, de Lemos JA, Ayers CR, Berry JD, Wang TJ. Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study. JACC Heart Fail. 2015 Jul;3(7):513-519. doi: 10.1016/j.jchf.2015.02.008. Epub 2015 Jun 10.
Results Reference
background
PubMed Identifier
25999400
Citation
Gupta DK, Claggett B, Wells Q, Cheng S, Li M, Maruthur N, Selvin E, Coresh J, Konety S, Butler KR, Mosley T, Boerwinkle E, Hoogeveen R, Ballantyne CM, Solomon SD. Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study. J Am Heart Assoc. 2015 May 21;4(5):e001831. doi: 10.1161/JAHA.115.001831.
Results Reference
background

Learn more about this trial

The Natriuretic Peptide System in African-Americans.

We'll reach out to this number within 24 hrs